The acquired six product lines include Lopressor (metoprolol tartrate USP) excluding Lopressor injection, Lopressor HCT , Lotensin, Lotensin HCT, Parlodel and Methergine. Post acquisition, Validus will be the
Instaflex is presently sold through the brand’s website as well as other food, drug and mass market retailers. Instaflex Joint Support improves life through extended mobility, enhanced flexibility,
The $17.9m contract from National Institutes of Health (NIH) aims to develop and enhance efficacy of MVA-BN-based human vaccine against the viral hemorrhagic fever Marburg. The other $1m
The primary endpoint of the placebo-controlled, multi-center study was achieved in 54% patients administered with pregabalin, compared to 70.7% patients in the placebo group. A statistically significant difference
Used to treat fungus infections, the Ultramicrosize Griseofulvin tablets had sales nearly of $16.7m for the twelve months ended 30 June 2012 in the US market, according to
According to the pre-clinical research alliance, CFFT will spend $58m to advance the drug candidates into clinical trials by the end of agreement period of six years. CF
The company submitted a supplemental new drug application (sNDA) based on the data from randomized, controlled Phase 3 EURTAC trial conducted in patients with EGFR triggering mutation-positive advanced
Promacta, brand name of eltrombopag in the US, will enable thrombocytopenia patients suffering from chronic hepatitis C to commence and sustain interferon-based therapy. GlaxoSmithKline oncology president Paolo Paoletti
Clontech researchers, who have participated in SnapGene beta testing, have also assisted SnapGene’s developers on the interface and functionality, which includes SnapGene’s ability to simulate Clontech’s In-Fusion cloning.
Subsequent to the Phase I patient safety data review, a Safety Monitoring Committee authorised the enrolment for the consequential Phase II study. Phase II trial is expected to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.